Welcome to our dedicated page for JLens 500 Jewish Advocacy U.S. ETF news (Ticker: TOV), a resource for investors and traders seeking the latest updates and insights on JLens 500 Jewish Advocacy U.S. ETF stock.
JLens 500 Jewish Advocacy U.S. ETF (TOV) provides investors with values-aligned exposure to U.S. equities through its unique advocacy-focused methodology. This news hub offers comprehensive coverage of official fund developments and market analysis.
Access real-time updates on portfolio adjustments, management insights, and sector-specific developments. Our curated collection includes earnings reports, governance changes, and strategic partnership announcements – all essential for understanding this thematic ETF's market position.
Key coverage areas: quarterly performance summaries, constituent company updates, screening criteria enhancements, and comparative market analysis. Each update maintains focus on the fund's dual objectives of financial performance and advocacy alignment.
Bookmark this page for streamlined access to TOV's latest developments. Combine regular monitoring with our historical archive to track evolving trends in ethical ETF investing.
JLens, sponsor of the JLens 500 Jewish Advocacy U.S. ETF (NYSE: TOV), has urged shareholders to vote against specific proposals at upcoming General Dynamics (GD) and Lockheed Martin (LMT) annual meetings. The proposals in question request a Human Rights Impact Assessment at GD and an evaluation of political activities alignment with human rights policy at LMT.
The shareholder votes are scheduled for May 7, 2025 (GD) and May 9, 2025 (LMT). JLens argues these proposals are motivated by the BDS (Boycott, Divestment, and Sanctions) movement and aim to pressure companies to cut ties with Israel. Both companies' Boards of Directors have recommended voting AGAINST these proposals.
The TOV ETF, launched with ADL support, aims to combat what they describe as antisemitic and anti-Israel activities in corporate governance. JLens has filed Notices of Exempt Solicitation with the SEC opposing both proposals.
The JLens 500 Jewish Advocacy U.S. ETF (NYSE:TOV) has surpassed $100 million in assets within two weeks of its February 27, 2025 launch on the New York Stock Exchange. The fund, whose ticker 'TOV' means 'good' in Hebrew, aims to match U.S. Large Cap index fund performance while advancing Jewish advocacy in corporate settings.
The milestone was achieved partly through seed capital from several U.S. Jewish organizations and the ADL Foundation. TOV tracks the JLens 500 Jewish Advocacy U.S. Index, investing in America's 500 largest public companies, screening and scoring them based on Jewish values alignment. The fund employs an 'own and advocate' approach, engaging with management, boards, proxy voting, and shareholder advocacy.
The ETF's creation was prompted by the surge in antisemitism following October 7, 2023, particularly addressing BDS movement actions against corporations and workplace hostility toward Jewish employees. The fund is sponsored by JLens, a Registered Investment Advisor and ADL affiliate, with Empowered Funds serving as Fund Advisor.
JLens has launched the first-ever Jewish Advocacy ETF (TOV) on the NYSE, backed by over $100 million in seed capital from the ADL Foundation and various Jewish organizations. The ETF tracks the JLens 500 Jewish Advocacy U.S. Index, investing in America's 500 largest public companies while screening out those misaligned with Jewish values.
The fund, trading under ticker symbol 'TOV' (Hebrew for 'good'), aims to combat antisemitism and support Israel through shareholder advocacy, management engagement, and proxy voting. The launch comes in response to unprecedented antisemitic incidents, with ADL reporting over 10,000 cases in the year following October 7, 2023. According to JLens research, more than 75 of the 500 largest U.S. public corporations were targeted by the BDS movement in the past year.